Background: This study aimed at providing insight in the frequency, emotional impact and nature of daily hassles, experienced by patients suffering from chronic fatigue syndrome (CFS) and/or fibromyalgia (FM), compared with patients with a chronic organic disease. Methods: One hundred and seventy-seven CFS/FM patients, 26 multiple sclerosis (MS) and 26 rheumatoid arthritis (RA) patients were investigated within 2–6 months after diagnosis. All patients completed a self-report questionnaire assessing daily hassles and associated distress, a visual analogue scale assessing fatigue and pain and a depression and anxiety questionnaire. Results: CFS/FM patients show a higher frequency of hassles, higher emotional impact and higher fatigue, pain, depression and anxiety levels compared with MS/RA patients. Three hassle themes dominate in the CFS/FM group: dissatisfaction with oneself, insecurity and a lack of social recognition. In contrast, hassles reported by MS/RA patients show a much larger diversity and are not focused on person-dependent problems. Conclusions: Patients recently diagnosed as suffering from CFS and/or FM are highly preoccupied and distressed by daily hassles that have a severe impact on their self-image, as well as their personal, social and professional functioning. An optimal therapeutic approach of CFS and FM should take account of this heavy psychosocial burden, which might refer to core themes of these patients’ illness experience.

Keywords:
Chronic fatigue syndrome, Fibromyalgia, Daily hassles, Stress, Anxiety, Depression, Psychotherapy
1.
Wessely S, Sharpe M, Hotopf M: Chronic Fatigue and Its Syndromes. Oxford, Oxford University Press, 1998.
2.
Goldenberg D: Fibromyalgia syndrome a decade later: What have we learned? Arch Intern Med 1999;159:777–785.
3.
Buchwald D: Fibromyalgia and chronic fatigue syndrome: Similarities and differences. Rheum Dis Clin North Am 1996;22:219–243.
4.
Clauw DJ, Chrousos GP: Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:134–153.
5.
Wessely S, Nimnuan C, Sharpe M: Functional somatic syndromes: One or many? Lancet 1999;354:936–939.
6.
Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S, Terenius L, Henriksson KG: Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998;78:153–155.
7.
Cleare A, Wessely S: Chronic fatigue syndrome: A stress disorder? Br J Hosp Med 1996;55:571–574.
8.
Dobbins J, Natelson B, Brassloff R: Physical, behavioural and psychological risk factors for chronic fatigue syndrome: A central role for stress? J Chron Fat Syndr 1995;1:43–58.
9.
Okifuji A, Turk DC: Fibromyalgia: Search for mechanisms and effective treatments; in Gatchel RJ, Turk DC (eds): Psychosocial Factors in Pain. Critical Perspectives. New York, Guilford, 1999, pp 227–246.
10.
Theorell T, Blomkvist V, Lindh G, Evengard B: Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): An examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999;61:304–310.
11.
Skapinakis P, Lewis G, Meltzer H: Clarifying the relationship between unexplained chronic fatigue and psychiatric mobidity: Results from a community survey in Great Britain. Am J Psychiatry 2000;157:1492–1498.
12.
Eich W, Hartmann M, Müller A, Fischer H: The role of psychosocial factors in fibromyalgia syndrome. Scand J Rheumatol Suppl 2000;29:30–31.
13.
Anderberg UM, Marteinsdottir I, Theorell T, von Knorring L: The impact of life events in female patients with fibromyalgia and in female healthy controls. Eur Psychiatry 2000;15:295–301.
14.
Walker EA, Keegan D, Gardner G, Sullivan M, Katon W, Bernstein D, Katon WJ: Psychosocial factors in fibromyalgia compared with rheumatoid arthritis. II. Sexual, physical, and emotional abuse and neglect. Psychosom Med 1997;59:572–577.
15.
Van Houdenhove B, Neerinckx E, Lysens R, Vertommen H, Van Houdenhove L, Onghena P, Westhovens R, D’Hooghe B: Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: A controlled study on prevalence and characteristics. Psychosomatics 2001;421:21–28.
16.
Van Houdenhove B, Neerinckx E, Onghena P, Hellin J: Does high ‘action-proneness’ make people more vulnerable to chronic fatigue syndrome? A controlled psychometric study. J Psychosom Res 1995;39:633–640.
17.
Van Houdenhove B, Neerinckx E, Onghena P, Lysens R, Vertommen H: Premorbid ‘overactive’ lifestyle in chronic fatigue syndrome and fibromyalgia: An etiological factor or proof of good citizenship? J Psychosom Res 2001;51:571–576.
18.
Schweitzer R, Kelly B, Foran A, Terry D, Whiting J: Quality of life in chronic fatigue syndrome. Soc Sci Med 1995;41:1367–1372.
19.
Knussen C, Lee D: Chronic fatigue syndrome: Symptoms, appraisal and ways of coping. Br J Health Psychol 1998;3:111–121.
20.
Jason LA, Fricano G, Taylor RR, Halpert J, Fenell PA, Klein S, Levine S: Chronic fatigue syndrome: An examination of the phases. J Clin Psychol 2000;56:1497–1508.
21.
Hallberg LRM, Carlsson SG: Coping with fibromyalgia. A qualitative study. Scand J Caring Sci 2000;14:29–36.
22.
Lutgendorf SK, Antoni MH, Ironson G, et al: Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of hurricane Andrew. Psychosom Med 1995;57:310–323.
23.
Wigers SH: Fibromyalgia outcome: The predictive value of symptom duration, physical activity, disability pension, and critical life events – a 4.5 year prospective study. J Psychosom Res 1996;41:235–243.
24.
Demitrack M, Crofford LJ: Evidence for and pathophysiological implications of hypothalamo-pituitary-adrenal axis dysregulations in fibromyalgia and chronic fatigue syndrome. Ann NY Acad Sci 1998;840:684–697.
25.
Weigent DA, Bradley LA, Blalock JE, Alarcon GS: Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia. Am J Med Sci 1998;315:405–412.
26.
Cleare AJ, Blair D, Chambers S, Wessely S: Urinary free cortisol in chronic fatigue syndrome. Am J Psychiatry 2001;158:641–643.
27.
Kanner AD, Coyne JC, Schaefer C, Lazarus RS: Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events. J Behav Med 1981;4:1–39.
28.
Dailey PA, Bishop GD, Russell JI, Fletcher EM: Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheumatol 1990;17: 1380–1385.
29.
Uveges JM, Parker JC, Smarr KL, McGowan JF, Lyon MG, Irvin MG, Meyer AA, Buckelew SP, Morgan RK, Delmonico RL, Hewett JE, Kay DR: Psychological symptoms in primary fibromyalgia syndrome: Relationship to pain, life stress, and sleep disturbance. Arthritis Rheum 1990;33:1279–1283.
30.
Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komaroff A: The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953–959.
31.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–172.
32.
Vingerhoets AJJM, van Tilburg MAL: Alledaagse problemenlijst. Lisse, Swets & Zeitlinger, 1994.
33.
Beck AT: Depression: Causes and Treatment. Philadelphia, University of Pennsylvania Press, 1972.
34.
Van der Ploeg HM, Defares PB, Spielberger CD: Handleiding bij de Zelfbeoordelingsvragenlijst. Een Nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory. Lisse, Swets & Zeilinger, 1980.
35.
SAS Institute Inc: SAS for Windows, version 6.12. Cary, SAS Institute, 1996.
36.
Siegel S, Castellan NJ Jr: Nonparametric statistics for the behavioral sciences, ed 2. New York, McGraw-Hill, 1988.
37.
Van Houdenhove B, Vasquez G, Neerinckx E: Tender points or tender patients? The value of the psychiatric in-depth interview for assessing and understanding psychopathological aspects of fibromyalgia. Clin Rheumatol 1994;13:470–474.
38.
Gaston-Johansson F, Gustafsson M, Felldin R, Sanne H: A comparative study of feelings, attitudes and behaviors of patients with fibromyalgia and rheumatoid arthritis. Soc Sci Med 1990;32:941–947.
39.
Johnson M, Paananen ML, Rahinantti P, Hannonen P: Depressed fibromyalgia patients are equipped with an emphatic competence-dependent self-esteem. Clin Rheumatol 1997;16:578–584.
40.
Powell R, Dolan R, Wessely S: Attributions and self-esteem in depression and chronic fatigue syndromes. J Psychosom Res 1990;34:665–673.
41.
Fry AM, Martin M: Fatigue in the chronic fatigue syndrome: A cognitive phenomenon. J Psychosom Res 1996;41:415–426.
42.
White C, Schweitzer R: The role of personality in the development and perpetuation of chronic fatigue syndrome. J Psychosom Res 2000;48:515–524.
43.
Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ, Spinhoven P, van der Meer JWM: Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomized controlled trial. Lancet 2001;257:841–847.
44.
Bennett RM: Multidisciplinary group programs to treat fibromyalgia. Rheum Dis Clins North Am 1996;22:351–367.
45.
Kroenke K, Swindle R: Cognitive-behavioral therapy for somatization and symptom syndromes: A critical review of controlled clinical trials. Psychother Psychosom 2000;69:205–215.
46.
Söderberg S, Evengard B: Short-term group therapy for patients with chronic fatigue syndrome. Psychother Psychosom 2001;70:108–111.
47.
Cuykx V, Van Houdenhove B, Neerinckx E: Childhood abuse, personality disorder and chronic fatigue syndrome. Gen Hosp Psychiatry 1998;20:382–384.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.